Allergic contact dermatitis in children: Review of the past decade

Current Allergy and Asthma Reports

Volumn 14, Issue 4, 2014, Pages

  Admani, Shehla ^a   Jacob, Sharon E ^a,b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergen; Allergic contact dermatitis; Allergic sensitization; Atopic dermatitis; Children; Patch test; Pediatric

Indexed keywords

2 METHYL 4 ISOTHIAZOLIN 3 ONE; 5 CHLORO 2 METHYL 4 ISOTHIAZOLIN 3 ONE; ALLERGEN; BACITRACIN; BALSAM PERU; BUDESONIDE; COBALT; CONTACT ALLERGEN; CORTICOSTEROID; DESONIDE; DICHROMATE POTASSIUM; FLUOCINONIDE; FORMALDEHYDE; FRAGRANCE; GOLD; HAND SANITIZER; LANOLIN ALCOHOL; NEOMYCIN; NICKEL; STEROID; THIOMERSAL; TRIAMCINOLONE;

ATOPIC DERMATITIS; CHILDHOOD DISEASE; CONTACT SENSITIZATION; CORTICOSTEROID THERAPY; HUMAN; PATCH TEST; PRICK TEST; QUALITY OF LIFE; RADIOALLERGOSORBENT TEST; REVIEW; SCREENING; SKIN ALLERGY; ANIMAL; CHILD; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY;

ALLERGENS; ANIMALS; CHILD; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATCH TESTS;

EID: 84893198894     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0421-0     Document Type: Review

References (74)

1. Jacob SE, and Herro EM. Practical Patch Testing and Chemical Allergens in Contact Dermatitis. Lexington: Springer, 2013. pp 13-20,86,112,113. Print.
2. Mydlarski PR, Katz AM, Mamelak AJ, et al. Contact Dermatitis. In: Adkinson NF, Yunginger JW, Busse WW, editors. Middleton's allergy principles and practice. Philadephia: Mosby; 2014. p. 565-79.
3. Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013;14(5):389-99.
4. Gimenez-Arnau A, Maurer M, De La Cuadra J, Maibach H. Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis - "A Never Ending Story". Eur J Dermatol. 2010;20(5):552-62.
5. McFadden J. Immunologic contact urticaria. Immunol Allergy Clin N Am. 2014;34(1):157-67.
6. Hjorth N, Roed-Peterson J.Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28-42.
7. Rieman H, Schwarz T, Grabbe S. Pathomechanisms of the eleicitation phase of allergic contact dermatitis. J Dtsch Dermatol Ges. 2003;1(8):613-9. (Pubitemid 37128306)
8. Janeway C, Travers P, Walport M, Shlomehik M. Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Science Publishing; 2005.
9. Nijhawen RI, Matic C, Jacob SE. Contact dermatitis: from basics to allergodromes. Pediatr Ann. 2009;38(2):99-108.
10. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18:385-90. (Pubitemid 44258995)
11. Elsaie ML, Olasz E, Jacob SE. Cytokines and langerhan cells in allergic contact dermatitis. G Ital Dermatol Venereol. 2008;143(3):195-205. (Pubitemid 351946833)
12. Straus HW. Artificial sensitization of infants to poison ivy. J Allergy. 1931;2(3):137-44.
13. Weston WL, Weston JA, Kinoshita J, et al. Prevalence of positive epicutaneous tests among infants, children, and adolescents. Pediatrics. 1986;78(6):1070-4. (Pubitemid 17190248)
14. Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics. 2000;105(1):e3.
15. Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children-a United States based study. Pediatr Dermatol. 2008;25(5):520-7.
16. Zug KA, McGinley-Smith D, Warshaw EM, et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol. 2008;144(10):1329-36.
17. Hogeling M, Pratt M. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006. Dermatitis. 2008;19(2):86-9. (Pubitemid 351798322)
18. Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis. 2011;22(4):204-10.
19. Jacob SE, Yang A, Herro E, Zhang C. Contact allergens in a pediatric population: association with atopic dermatitis and comparison with other north American referral centers. J Clin Aesthet Dermatol. 2010;3(10):29-35.
20. Lewis VJ, Statham BN, Chowdhury MM. Allergic contact dermatitis in 191 consecutively patch tested children. Contact Dermatitis. 2004;51(3):155-6. (Pubitemid 39423067)
21. Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis. 2004;51(3):111-7. (Pubitemid 39423054)
22. Clayton TH, Wilkinson SM, Rawcliffe C, Pollock B, Clark SM. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one U.K. centre. Br J Dermatol. 2006;154(1):114-7. (Pubitemid 43381329)
23. Goon AT, Goh CL. Patch testing of Singapore children and adolescents: our experience over 18 years. Pediatr Dermatol. 2006;23(2):117-20.
24. Beattie PE, Green C, Lowe G, Lewis-Jones MS. Which children should we patch test? Clin Exp Dermatol. 2007;32(1):6-11. (Pubitemid 46006357)
25. Onder M, Adisen E. Patch test results in a Turkish paediatric population. Contact Dermatitis. 2008;58(1):63-5. (Pubitemid 350264753)
26. Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol. 2008;25(1):81-7. (Pubitemid 351315459)
27. de Waard-vander Spek FB, Oranje AP. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature. Dermatology. 2009;218(2):119-25.
28. Mailhol C, Lauwers-Cances V, Rancé F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64(5):801-6.
29. Hammonds LM, Hall VC, Yiannias JA. Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. Int J Dermatol. 2009;48(3):271-4.
30. Belloni Fortina A, Romano I, Peserico A, Eichenfield LF. Contact sensitization in very young children. J Am Acad Dermatol. 2011;65(4):772-9.
31. Kuljanac I, Knežević E, Cvitanović H. Epicutaneous patch test results in children and adults with allergic contact dermatitis in Karlovac county: a retrospective survey. Acta Dermatovenerol Croat. 2011;19(2):91-7.
32. Schena D, Papagrigoraki A, Tessari G, Peroni A, Sabbadini C, Girolomoni G. Allergic contact dermatitis in children with and without atopic dermatitis. Dermatitis. 2012;23(6):275-80.
33. Silny W, Bartoszak L, Jenerowicz D, Żukiewicz-Sobczak W, Goździewska M. Prevalence of contact allergy in children suffering from atopic dermatitis, seborrhoeic dermatitis and in healthy controls. Ann Agric Environ Med. 2013;20(1):55-60.
34. Worm M, Aberer W, Agathos M, et al. Patch testing in children- recommendations of the German Contact Dermatitis Research Group (DKG). J Dtsch Dermatol Ges. 2007;5(2):107-9. (Pubitemid 46212726)
35. Jacob SE, Steele T, Brod B, Crawford GH. Dispelling the myths behind pediatric patch testing-experience from our tertiary care patch testing centers. Pediatr Dermatol. 2008;25(3):296-300. (Pubitemid 351813949)
36. Matiz C, Hsu JW, Paz Castanedo-Tardan M, Jacob SE. Allergic contact dermatitis in children: a review of international studies. G Ital Dermatol Venereol. 2009;144(5):541-56.
37. Jacob SE, Breithaupt A. Environmental Exposures- A Pediatric Perspective on Allergic Contact Dermatitis. Skin and, Aging. 2009 Jul:28-36.
38. Nelson JL, Mowad CM. Allergic Contact Dermatitis: Patch Testing Beyond the TRUE Test. J Clin Aesthet Dermatol. 2010;3(10):36-41.
39. Pigatto P, Martelli A, Marsili C, Fiocchi A. Contact dermatitis in children. Ital J Pediatr. 2010;36:2.
40. Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514-20.
41. Jacob SE, Miller JM, Herro EM. Treating Atopic Dermatitis: Tips for Maintaining an Effective Epidermal Barrier. Skin and, Aging. 2011 Jan:s3-10.
42. Fonacier LS, Aquino MR, Mucci T. Current strategies in treating severe contact dermatitis in pediatric patients. Curr Allergy Asthma Rep. 2012;12(6):599-606.
43. "Thimerosal and 2013-2014 Seasonal Flu Vaccines". Centers for Disease Control and Prevention. CDC, 3 Sep 2013. Web. 12 Dec 2013.
44. Nijhawan RI, Jacob SE. Connubial dermatitis revisited: mother-to-child contact dermatitis. Dermatitis. 2009;20:55-7.
45. Hsu JW, Matiz C, Jacob SE. Nickel allergy: localized, id, and systemic manifestations in children. Pediatr Dermatol. 2011;28(3):276-80.
46. Nijhawan RI, Molenda M, Zirwas MJ, Jacob SE. Systemic contact dermatitis. Dermatol Clin. 2009;27:355-64.
47. Szyfelbein Masterpol K, Gottlieb AB, Scheinman PL. Systemic contact dermatitis presenting as lichen planus of the lip. Dermatitis. 2010;21:218-319.
48. Wentworth AB, Yiannias JA, Keeling JH, et al. Trends in patch-test results and allergen changes in the standard series: A Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). J Am Acad Dermatol. 2013 Nov 20.
49. Warshaw EM, Belsito DV, Taylor JS, et al. North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis. 2013;24(2):50-9.
50. Castanedo-Tardana MP, Zug KA.Methylisothiazolinone. Dermatitis. 2013;24(1):2-6.
51. Jacob SE, Stechschulte S. Eyelid dermatitis associated with balsamof Peru constituents: benzoic acid and benzyl alcohol. Contact Dermatitis. 2008;58(2):111-2.
52. Morioka Y, Yamasaki K, Leung D, Gallo RL. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J Immunol. 2008;181(6):3915-22.
53. Di Nardo A, Braff MH, Taylor KR, et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol. 2007;178(3):1829-34. (Pubitemid 46154655)
54. Hanifin JM. Filaggrin mutations and allergic contact sensitization. J Invest Dermatol. 2008;128(6):1362-4. (Pubitemid 351693213)
55. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164(5):2405-11. (Pubitemid 30115468)
56. Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol. 1989;125(3):366-8. (Pubitemid 19078244)
57. Lobitz Jr WC, Honeyman JF, Winkler NW. Suppressed cell-mediated immunity in two adults with atopic dermatitis. Br J Dermatol. 1972;86(4):317-28.
58. Newell L, Polak ME, Perera J, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol. 2013;133(10):2372-80.
59. Lammintausta K, Kalimo K, Fagerlund VL. Patch test reactions in atopic patients. Contact Dermatitis. 1992;26(4):234-40.
60. Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis. 2008;58(3):188-9. (Pubitemid 351248568)
61. Oranje AP, Bruynzeel DP, Stenveld HJ, Dieges PH. Immediate- and delayed-type contact hypersensitivity in children older than 5 years with atopic dermatitis: a pilot study comparing different tests. Pediatr Dermatol. 1994;11(3):209-15. (Pubitemid 24275800)
62. Holden CR, Gawkrodger DJ. 10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important? Contact Dermatitis. 2005;53(1):37-9. (Pubitemid 40977219)
63. Cronin H, Mowad C. Anaphylactic reaction to bacitracin ointment. Cutis. 2009;83(3):127-9.
64. Usmani N, Wilkinson SM. Allergic skin disease: investigation nof both immediate- and delayed-type hypersensitivity is essential. Clin Exp Allergy. 2007;37(10):1541-6. (Pubitemid 47460232)
65. Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232-5. (Pubitemid 29195156)
66. Fisher AA. Childhood allergic contact dermatitis. Cutis. 1975;15:635-42.
67. Package insert for Thin-Layer Rapid Use Epicutaneous Patch Test (T.R.U.E.)™, Smart Practice; Phoenix, Arizona. February 2012.
68. Wahlberg JE. Patch testing. In: Rycroft RJG, Menne T, Frosch PJ, Lepoittevin JP, editors. Textbook of contact dermatitis. 3rd ed Berlin: springer-Verlag; 2001. Pp. 435-68.
69. Anveden I, Lindberg M, Andersen KE, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis. 2004;50(5):298-303. (Pubitemid 38869904)
70. Fowler Jr JF, Maibach HI, Zirwas M, et al. Effects of immunomodulatory agents on patch testing: expert opinion 2012. Dermatitis. 2012;23(6):301-3.
71. Torchia D, Capretti C, Pizzo B, Francalanci S. Patch test triggering recurrence of distant dermatitis: the flare-up phenomenon. CMAJ. 2008;179(4):341.
72. Fisher AA. Perfume dermatitis in children sensitized to balsam of Peru in topical agents. Cutis. 1990;45(1):21-3. (Pubitemid 20109459)
73. Gelpi CB, Jacob SE. Instructions for educating patients on ROAT testing in conjunction with patch testing. Dermatol Nurs. 2008;20(2):139-43.
74. Rajagopalan R, Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermatitis. 1997;8:215-21.